BabySeq, ICoNS and the power of newborn sequencing: Q&A with Dr Robert Green

R.GreenR.Green
W.GreeneW.Greene
BulletArticle
Newborn Screening Leaders In Conversation Rare Diseases Sequencing
共有する：
リンクをコピーする
BabySeq, ICoNS and the power of newborn sequencing: Q&A with Dr Robert Green

Dr Robert Green is a physician-scientist who has spent much of his career at the forefront of the exciting field of translational genomics. In this Q&A with Will Greene, Healthcare Engagement Lead at Roche Diagnostics Asia Pacific, Dr Green talks about his pioneering work in newborn sequencing, including via the BabySeq project and the International Consortium on Newborn Sequencing (ICoNS), as well as his broader efforts to make genomic information actionable and accessible for people everywhere.

共有する：
リンクをコピーする

同じトピックの記事

Undiagnosable? This clinical research network can help

Exome sequencing improves rare disease diagnostics in Taiwan

おすすめのトピック

SequencingRED 2020Rare Diseases
次のおすすめ記事
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top